Tan NGUYEN

Person

Fullerton, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fusion proteins for inhibiting angiogenesis
- Patent number 12,152,057
- Issue date Nov 26, 2024
- Allgenesis Biotherapeutics Inc.
- Pei-Tzu Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGFR fusion protein pharmaceutical composition
- Patent number 11,723,955
- Issue date Aug 15, 2023
- Allgenesis Biotherapeutics Inc.
- Tan Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ophthalmic formulations of tyrosine kinase inhibitors, methods of u...
- Patent number 11,369,600
- Issue date Jun 28, 2022
- Allgenesis Biotherapeutics Inc.
- Tan Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ophthalmic formulations of tyrosine kinase inhibitors, methods of u...
- Patent number 10,154,994
- Issue date Dec 18, 2018
- Allgenesis Biotherapeutics, Inc.
- Tan Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
FUSION PROTEINS FOR INHIBITING ANGIOGENESIS
- Publication number 20250051404
- Publication date Feb 13, 2025
- Allgenesis Biotherapeutics Inc.
- Pei-Tzu WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...
- Publication number 20240408083
- Publication date Dec 12, 2024
- Allgenesis Biotherapeutics Inc.
- Tan NGUYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGFR Fusion Protein Pharmaceutical Composition
- Publication number 20230364185
- Publication date Nov 16, 2023
- Allgenesis Biotherapeutics Inc.
- Tan Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...
- Publication number 20220280506
- Publication date Sep 8, 2022
- Allgenesis Biotherapeutics Inc.
- Tan NGUYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS FOR INHIBITING ANGIOGENESIS
- Publication number 20200181214
- Publication date Jun 11, 2020
- Allgenesis Biotherapeutics Inc.
- Pei-Tzu WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...
- Publication number 20180243294
- Publication date Aug 30, 2018
- Allgenesis Biotherapeutics Inc.
- Tan NGUYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...
- Publication number 20170368061
- Publication date Dec 28, 2017
- Allgenesis Biotherapeutics Inc.
- Tan NGUYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Fusion proteins for inhibiting angiogenesis

VEGFR fusion protein pharmaceutical composition

Ophthalmic formulations of tyrosine kinase inhibitors, methods of u...

Ophthalmic formulations of tyrosine kinase inhibitors, methods of u...

Patents Applicationslast 30 patents

FUSION PROTEINS FOR INHIBITING ANGIOGENESIS

OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...

VEGFR Fusion Protein Pharmaceutical Composition

OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...

FUSION PROTEINS FOR INHIBITING ANGIOGENESIS

OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...

OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...